Biogen
Trade Biogen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis.
BIIB Key Statistics
Stock Snapshot
Biogen(BIIB) stock is priced at $191.82, giving the company a market capitalization of 28.15B. It carries a P/E multiple of 21.82.
On 2026-03-01, Biogen(BIIB) stock moved within a range of $186.62 to $192.44. With shares now at $191.82, the stock is trading +2.8% above its intraday low and -0.3% below the session's peak.
Trading activity shows a volume of 1.4M, compared to an average daily volume of 1.01M.
Over the past 52 weeks, Biogen(BIIB) stock has traded between a high of $202.41 and a low of $110.04.
Over the past 52 weeks, Biogen(BIIB) stock has traded between a high of $202.41 and a low of $110.04.
BIIB News
Biogen is advancing its Alzheimer’s treatment pipeline, with mid year clinical results for its BIIB080 drug candidate expected in the coming months. The compan...
Analyst ratings
54%
of 37 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.